
Spinal radiosurgery for metastatic disease
Department of Radiation Oncology, Stanford University, Stanford, CA
Management of metastatic spinal disease, which affects more than 100,000 patients yearly, is a continuing challenge. Treatment of symptomatic lesions often includes radiotherapy to control pain and neurologic symptoms. Advances in the delivery of radiation have allowed the implementation of radiosurgical principles, initially developed for the treatment of intracranial disease, to extracranial sites such as the spine. The authors examine the rationale behind the increasingly common use of spinal stereotactic radiosurgery, some of the initial data supporting it, and its potential advantages over conventional fractionated radiotherapy.
| Commun Oncol 2007;4:589592 | full text |